• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FbpA 和 FbpB 是具有不同结构和功能的免疫调节外表面脂蛋白。

FbpA and FbpB Are Immunomodulatory Outer Surface Lipoproteins With Distinct Structures and Functions.

机构信息

Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC, United States.

Department of Microbial Pathogenesis and Immunology, College of Medicine, Texas A&M University, Bryan, TX, United States.

出版信息

Front Immunol. 2022 May 27;13:886733. doi: 10.3389/fimmu.2022.886733. eCollection 2022.

DOI:10.3389/fimmu.2022.886733
PMID:35693799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9186069/
Abstract

Pathogens that traffic in the blood of their hosts must employ mechanisms to evade the host innate immune system, including the complement cascade. The Lyme disease spirochete, , has evolved numerous outer membrane lipoproteins that interact directly with host proteins. Compared to Lyme disease-associated spirochetes, relatively little is known about how an emerging tick-borne spirochetal pathogen, , utilizes surface lipoproteins to interact with a human host. expresses the multifunctional lipoprotein, BBK32, that inhibits the classical pathway of complement through interaction with the initiating protease C1r, and also interacts with fibronectin using a separate intrinsically disordered domain. encodes two separate orthologs denoted and ; however, the activities of these proteins are unknown. Here, we show that FbpA binds human fibronectin in a manner similar to BBK32, whereas FbpB does not. FbpA and FbpB both bind human complement C1r and protect a serum-sensitive strain from complement-mediated killing, but surprisingly, differ in their ability to recognize activated C1r versus zymogen states of C1r. To better understand the observed differences in C1r recognition and inhibition properties, high-resolution X-ray crystallography structures were solved of the C1r-binding regions of FbpA and FbpB at 1.9Å and 2.1Å, respectively. Collectively, these data suggest that FbpA and FbpB have partially overlapping functions but are functionally and structurally distinct. The data presented herein enhances our overall understanding of how bloodborne pathogens interact with fibronectin and modulate the complement system.

摘要

病原体在宿主血液中传播时,必须采用机制来逃避宿主固有免疫系统,包括补体级联反应。莱姆病螺旋体 , 已经进化出许多直接与宿主蛋白相互作用的外膜脂蛋白。与莱姆病相关的螺旋体相比,人们对新兴的蜱传螺旋体病原体 , 如何利用表面脂蛋白与人类宿主相互作用知之甚少。 表达多功能脂蛋白 BBK32,通过与起始蛋白酶 C1r 相互作用抑制补体经典途径,还使用单独的固有无序结构域与纤维连接蛋白相互作用。 编码两个单独的 直系同源物,分别表示为 和 ;然而,这些蛋白质的活性是未知的。在这里,我们表明 FbpA 以类似于 BBK32 的方式与人纤维连接蛋白结合,而 FbpB 则不结合。FbpA 和 FbpB 都与人补体 C1r 结合,并保护对补体介导杀伤敏感的 菌株,但令人惊讶的是,它们识别激活的 C1r 与 C1r 酶原状态的能力不同。为了更好地理解在 C1r 识别和抑制特性方面观察到的差异,我们以 1.9Å 和 2.1Å 的分辨率分别解决了 C1r 结合区的 FbpA 和 FbpB 的高分辨率 X 射线晶体结构。总的来说,这些数据表明 FbpA 和 FbpB 具有部分重叠的功能,但在功能和结构上是不同的。本文所提供的数据增强了我们对血液病原体如何与纤维连接蛋白相互作用并调节补体系统的整体理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/4c66f4c92ee2/fimmu-13-886733-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/d07316e20deb/fimmu-13-886733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/ecadb8dcb51d/fimmu-13-886733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/a478f5c70a07/fimmu-13-886733-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/da83615c84b5/fimmu-13-886733-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/f92c7caac154/fimmu-13-886733-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/afd07fc8a43a/fimmu-13-886733-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/4c66f4c92ee2/fimmu-13-886733-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/d07316e20deb/fimmu-13-886733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/ecadb8dcb51d/fimmu-13-886733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/a478f5c70a07/fimmu-13-886733-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/da83615c84b5/fimmu-13-886733-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/f92c7caac154/fimmu-13-886733-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/afd07fc8a43a/fimmu-13-886733-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e565/9186069/4c66f4c92ee2/fimmu-13-886733-g007.jpg

相似文献

1
FbpA and FbpB Are Immunomodulatory Outer Surface Lipoproteins With Distinct Structures and Functions.FbpA 和 FbpB 是具有不同结构和功能的免疫调节外表面脂蛋白。
Front Immunol. 2022 May 27;13:886733. doi: 10.3389/fimmu.2022.886733. eCollection 2022.
2
Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease- and relapsing fever-causing spirochetes.莱姆病和回归热螺旋体致病螺旋体补体蛋白酶 C1r 抑制剂蛋白的构象动力学。
J Biol Chem. 2023 Aug;299(8):104972. doi: 10.1016/j.jbc.2023.104972. Epub 2023 Jun 27.
3
"Conformational dynamics of C1r inhibitor proteins from Lyme disease and relapsing fever spirochetes".莱姆病和回归热螺旋体C1r抑制蛋白的构象动力学
bioRxiv. 2023 Mar 1:2023.03.01.530473. doi: 10.1101/2023.03.01.530473.
4
Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes.布氏疏螺旋体 BBK32 补体抑制结构域的结构测定为莱姆病螺旋体逃避经典途径补体提供了线索。
PLoS Pathog. 2019 Mar 21;15(3):e1007659. doi: 10.1371/journal.ppat.1007659. eCollection 2019 Mar.
5
Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex.伯氏疏螺旋体BBK32通过阻断C1补体复合物的激活来抑制经典途径。
PLoS Pathog. 2016 Jan 25;12(1):e1005404. doi: 10.1371/journal.ppat.1005404. eCollection 2016 Jan.
6
A Structural Basis for Inhibition of the Complement Initiator Protease C1r by Lyme Disease Spirochetes.莱姆病螺旋体抑制补体起始蛋白酶 C1r 的结构基础。
J Immunol. 2021 Dec 1;207(11):2856-2867. doi: 10.4049/jimmunol.2100815. Epub 2021 Nov 10.
7
Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing.莱姆病病原体的脂蛋白组筛选鉴定出抗体介导的补体杀伤抑制剂。
Proc Natl Acad Sci U S A. 2022 Mar 29;119(13):e2117770119. doi: 10.1073/pnas.2117770119. Epub 2022 Mar 21.
8
Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion.回归热螺旋体的 CihC/FbpC 同源物与宿主来源的参与黏附、纤维蛋白溶解和补体逃避的蛋白的多功能相互作用。
Front Immunol. 2024 Apr 25;15:1390468. doi: 10.3389/fimmu.2024.1390468. eCollection 2024.
9
The molecular determinants of classical pathway complement inhibition by OspEF-related proteins of Borrelia burgdorferi.伯氏疏螺旋体 OspEF 相关蛋白对经典途径补体抑制的分子决定因素。
J Biol Chem. 2024 May;300(5):107236. doi: 10.1016/j.jbc.2024.107236. Epub 2024 Mar 27.
10
Complement evasion strategies of Borrelia burgdorferi sensu lato.伯氏疏螺旋体属的补体逃避策略。
FEBS Lett. 2020 Aug;594(16):2645-2656. doi: 10.1002/1873-3468.13894. Epub 2020 Aug 11.

引用本文的文献

1
BBK32 attenuates antibody-dependent complement-mediated killing of infectious Borreliella burgdorferi isolates.BBK32可减弱抗体依赖性补体介导的对感染性伯氏疏螺旋体分离株的杀伤作用。
PLoS Pathog. 2025 Jul 24;21(7):e1013361. doi: 10.1371/journal.ppat.1013361. eCollection 2025 Jul.
2
Navigating infection by pathogenic spirochetes: The host-bacteria interface at the atomic level.应对致病性螺旋体感染:原子水平上的宿主-细菌界面
Protein Sci. 2025 Jul;34(7):e70185. doi: 10.1002/pro.70185.
3
Role of Dual Specificity Phosphatase 1 (DUSP1) in influencing inflammatory pathways in macrophages modulated by lipoproteins.

本文引用的文献

1
Frequency and Geographic Distribution of Borrelia miyamotoi, Borrelia burgdorferi, and Babesia microti Infections in New England Residents.新英格兰居民中宫本疏螺旋体、伯氏疏螺旋体和微小巴贝斯虫感染的频率及地理分布
Clin Infect Dis. 2022 Mar 23. doi: 10.1093/cid/ciac107.
2
Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing.莱姆病病原体的脂蛋白组筛选鉴定出抗体介导的补体杀伤抑制剂。
Proc Natl Acad Sci U S A. 2022 Mar 29;119(13):e2117770119. doi: 10.1073/pnas.2117770119. Epub 2022 Mar 21.
3
A Structural Basis for Inhibition of the Complement Initiator Protease C1r by Lyme Disease Spirochetes.
双特异性磷酸酶1(DUSP1)在影响脂蛋白调节的巨噬细胞炎症途径中的作用。
bioRxiv. 2024 Nov 21:2024.11.20.624562. doi: 10.1101/2024.11.20.624562.
4
Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion.回归热螺旋体的 CihC/FbpC 同源物与宿主来源的参与黏附、纤维蛋白溶解和补体逃避的蛋白的多功能相互作用。
Front Immunol. 2024 Apr 25;15:1390468. doi: 10.3389/fimmu.2024.1390468. eCollection 2024.
5
nymph saliva protein blocks host inflammation and complement-mediated killing of Lyme disease agent, .泌离蛋白抑制莱姆病病原体,阻止宿主炎症和补体介导的杀伤。
Front Cell Infect Microbiol. 2023 Oct 26;13:1253670. doi: 10.3389/fcimb.2023.1253670. eCollection 2023.
6
"Conformational dynamics of C1r inhibitor proteins from Lyme disease and relapsing fever spirochetes".莱姆病和回归热螺旋体C1r抑制蛋白的构象动力学
bioRxiv. 2023 Mar 1:2023.03.01.530473. doi: 10.1101/2023.03.01.530473.
7
: A Comprehensive Review.全面综述。
Pathogens. 2023 Feb 7;12(2):267. doi: 10.3390/pathogens12020267.
莱姆病螺旋体抑制补体起始蛋白酶 C1r 的结构基础。
J Immunol. 2021 Dec 1;207(11):2856-2867. doi: 10.4049/jimmunol.2100815. Epub 2021 Nov 10.
4
Vitronectin binding protein, BOM1093, confers serum resistance on Borrelia miyamotoi.玻连蛋白结合蛋白 BOM1093 赋予伯氏疏螺旋体血清抗性。
Sci Rep. 2021 Mar 9;11(1):5462. doi: 10.1038/s41598-021-85069-w.
5
Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement.伯氏疏螺旋体可变主要蛋白 Vlp15/16 和 Vlp18 与纤溶酶原和补体的相互作用。
Sci Rep. 2021 Mar 2;11(1):4964. doi: 10.1038/s41598-021-84533-x.
6
More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.不止一个孔:补体的非裂解性抗菌功能和细菌逃避的策略。
Microbiol Mol Biol Rev. 2021 Jan 27;85(1). doi: 10.1128/MMBR.00177-20. Print 2021 Feb 17.
7
Pathogenesis of Relapsing Fever.回归热的发病机制。
Curr Issues Mol Biol. 2021;42:519-550. doi: 10.21775/cimb.042.519. Epub 2020 Dec 29.
8
Lyme Disease Pathogenesis.莱姆病发病机制。
Curr Issues Mol Biol. 2021;42:473-518. doi: 10.21775/cimb.042.473. Epub 2020 Dec 23.
9
Lyme Disease in Humans.人类莱姆病。
Curr Issues Mol Biol. 2021;42:333-384. doi: 10.21775/cimb.042.333. Epub 2020 Dec 11.
10
Targeting the Initiator Protease of the Classical Pathway of Complement Using Fragment-Based Drug Discovery.靶向补体经典途径起始蛋白酶的基于片段的药物发现。
Molecules. 2020 Sep 3;25(17):4016. doi: 10.3390/molecules25174016.